APA

Van Hoeven N., Joshi S. W., Nana G. I., Bosco-Lauth A., Fox C., Bowen R. A., Clements D. E., Martyak T., Parks D. E., Baldwin S., Reed S. G. & Coler R. N. (20160714). A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations. : PloS one.

Chicago

Van Hoeven Neal, Joshi Sharvari Waghmare, Nana Ghislain Ismael, Bosco-Lauth Angela, Fox Christopher, Bowen Richard A, Clements David E, Martyak Timothy, Parks D Elliot, Baldwin Susan, Reed Steven G and Coler Rhea N. 20160714. A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations. : PloS one.

Harvard

Van Hoeven N., Joshi S. W., Nana G. I., Bosco-Lauth A., Fox C., Bowen R. A., Clements D. E., Martyak T., Parks D. E., Baldwin S., Reed S. G. and Coler R. N. (20160714). A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations. : PloS one.

MLA

Van Hoeven Neal, Joshi Sharvari Waghmare, Nana Ghislain Ismael, Bosco-Lauth Angela, Fox Christopher, Bowen Richard A, Clements David E, Martyak Timothy, Parks D Elliot, Baldwin Susan, Reed Steven G and Coler Rhea N. A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations. : PloS one. 20160714.